FDA NDC Directory · JSON-LD · Markdown

Lisdexamfetamine dimesylate

NDC 0480-3564 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerTeva Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202802
Dosage form / routeCAPSULE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (70 mg/1)
Marketing started20241217
Package count1

External sources

Source: openFDA. Public-domain (CC0).